IMGN logo

Immunogen Inc

IMGN

IMGN: Immunogen Inc is a clinical-stage biotechnology company from the United States. Its focus is antibody-drug conjugate, or ADC, technology, which uses an antibody that fixes on a target (its antigen) found on tumor cells to deliver a specific cancer-killing agent.

more

Show IMGN Financials

Chart and Financial Data provided by TradingView

All
Government
Consumer Interest
SEC Filings
ESG/Other
Congress Trading

Recent trades of IMGN by members of U.S. Congress

Politician Type Traded
Thomas Macarthur House / R Purchase $1,001 - $15,000 Jan. 09, 2017
Thomas Macarthur House / R Sale $1,001 - $15,000 Dec. 08, 2016
Whale Activity

Recently reported changes by institutional investors

Quiver Logo

No Whale Activity for this ticker

Institutional Holdings Dashboard
Insider Trading

Quarterly net insider trading by IMGN's directors and management

Corporate Lobbying

Government lobbying spending instances

  • $20,000 Jul 20, 2023 Issue: Medicare/Medicaid Health Issues
  • $20,000 Apr 19, 2023 Issue: Health Issues
  • $20,000 Jan 19, 2023 Issue: Medicare/Medicaid Health Issues Budget/Appropriations
  • $20,000 Oct 19, 2022 Issue: Medicare/Medicaid Health Issues
  • $20,000 Jul 18, 2022 Issue: Medicare/Medicaid Health Issues
  • $20,000 Apr 19, 2022 Issue: Medicare/Medicaid Health Issues
  • $10,000 Jan 18, 2022 Issue: Medicare/Medicaid Health Issues
  • $20,000 Oct 18, 2021 Issue: Health Issues Medicare/Medicaid
  • $20,000 Jul 14, 2021 Issue: Medicare/Medicaid Health Issues
  • $20,000 Apr 13, 2021 Issue: Budget/Appropriations Health Issues Medicare/Medicaid
  • $20,000 Jan 18, 2021 Issue: Budget/Appropriations Health Issues Medicare/Medicaid
  • $20,000 Oct 15, 2020 Issue: Budget/Appropriations Health Issues Medicare/Medicaid
  • $20,000 Jul 14, 2020 Issue: Medicare/Medicaid Health Issues Budget/Appropriations
  • $20,000 Apr 15, 2020 Issue: Medicare/Medicaid Health Issues Budget/Appropriations
  • $20,000 Jan 16, 2020 Issue: Budget/Appropriations Health Issues Medicare/Medicaid
  • $20,000 Oct 14, 2019 Issue: Health Issues Medicare/Medicaid
  • $20,000 Jul 12, 2019 Issue: Health Issues Medicare/Medicaid
  • $20,000 Apr 15, 2019 Issue: Medicare/Medicaid
  • $10,000 Jan 16, 2019 Issue: Medicare/Medicaid
  • $20,000 Feb 14, 2003 Issue: Health Issues Medicare/Medicaid
  • $20,000 Aug 14, 2002 Issue: Health Issues Medicare/Medicaid
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

WallStreetBets

Number of mentions of IMGN in WallStreetBets Daily Discussion

IMGN News

Recent insights relating to IMGN

CNBC Recommendations

Recent picks made for IMGN stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in IMGN

Corporate Flights

Flights by private jets registered to IMGN